NCT06132113 2025-12-17
DAREONâ„¢-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers
Boehringer Ingelheim
Phase 1 Recruiting
Boehringer Ingelheim
Centre Hospitalier Universitaire Dijon
GERCOR - Multidisciplinary Oncology Cooperative Group